Lotus Eye Hospital Stock Screener | Share Price & Fundamental Analysis

LOTUSEYE Hospitals
Share Price NSE
₹107.36
▼ -0.12 (-0.11%)
2026-04-13 00:00:00
Share Price BSE
₹108.95
▲ 0.15 (0.14%)
2026-04-13 00:00:00
As of April 13, 2026, the Lotus Eye Hospital share price (NSE: LOTUSEYE) is ₹107.36 on NSE and ₹108.95 on BSE, down 0.11% from the previous close, with shares trading between ₹103.00 and ₹108.50, and a 52-week range of ₹65.03–₹141.38. Browse LOTUSEYE complete financial to support your investment research. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Lotus Eye Hospital Market Cap ₹224.58 Cr.
LOTUSEYE P/E Ratio (TTM) 350.97
Lotus Eye Hospital P/B Ratio 3.73
EPS (TTM) ₹0.36
Dividend Yield -
Debt to Equity 0.04
LOTUSEYE 52 Week High ₹141.38
Lotus Eye Hospital 52 Week Low ₹65.03
Operating Margin 5.00%
Profit Margin 1.89%
LOTUSEYE Revenue (TTM) ₹53.00
EBITDA ₹4.00
Net Income ₹1.00
Total Assets ₹70.00
Total Equity ₹60.00

Lotus Eye Hospital Share Price History - Stock Screener Chart

Screen LOTUSEYE historical share price movements with interactive charts. Analyze price trends and patterns.

Lotus Eye Hospital Company Profile - Fundamental Screener

Screen Lotus Eye Hospital company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for LOTUSEYE shares.
Sector Healthcare Services
Industry Hospitals
Sub-Sector Hospitals
Segment E
ISIN INE947I01017

Lotus Eye Hospital Balance Sheet Screener

Screen LOTUSEYE balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
Item 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016
Assets
Total Assets 70 67 63 62 59 58 57 58 55 55
Current Assets 12 14 15 13 14 11 7 8 7 6
Fixed Assets 54 49 44 44 41 43 44 43 41 44
Liabilities
Total Liabilities 0 0 0 0 0 0 0 0 0 0
Current Liabilities 2 1 0 1 1 1 1 1 1 1
Non-Current Liabilities 0 0 0 0 0 0 0 0 0 0
Shareholders' Equity
Total Equity 60 59 58 55 53 51 50 51 50 50
Share Capital 21 21 21 21 21 21 21 21 21 21
Reserves & Surplus 39 39 37 34 32 31 29 30 29 29

Lotus Eye Hospital Income Statement Screener - Profit & Revenue Analysis

Screen Lotus Eye Hospital income statement and profit fundamentals. Analyze LOTUSEYE quarterly results, revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Lotus Eye Hospital share price evaluation.
Item None-None 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March 2016-March 2015-March
Revenue 53 51 50 48 40 33 42 39 39 35 32 30
Expenses 49 46 42 40 33 29 37 35 34 31 27 28
EBITDA 4 5 8 9 7 4 5 4 5 4 5 3
Operating Profit % 5.00% 7.00% 14.00% 16.00% 15.00% 11.00% 9.00% 8.00% 11.00% 10.00% 13.00% 7.00%
Depreciation 2 3 4 3 3 2 3 3 3 3 4 5
Interest 1 0 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 1 1 4 6 4 2 2 1 2 0 0 -2
Tax 0 1 1 2 1 0 0 0 0 0 0 0
Net Profit 1 1 3 4 3 2 1 1 2 0 0 -2
EPS 0.30 0.36 1.40 1.96 1.44 0.75 0.51 0.34 0.84 0.21 0.05 -0.95

Lotus Eye Hospital Cash Flow Screener - Liquidity Fundamentals

Screen LOTUSEYE cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
Item 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March 2016-March
Operating Activities 3 6 4 4 3 5 4 6 3 3
Investing Activities -6 -5 -2 -4 1 -1 -4 -4 -1 -1
Financing Activities -2 -3 -2 -2 0 0 -1 -2 0 -1
Net Cash Flow -5 -2 1 -1 3 4 -1 0 2 2

Lotus Eye Hospital Shareholding Pattern Screener

See Lotus Eye Hospital shareholding pattern with promoter, FII, and DII holdings. Check Lotus Eye Hospital promoter holding and ownership changes for LOTUSEYE on TickJournal.
Item 2025-Dec 2025-Sept 2025-Jun 2025-Mar 2024-Dec 2024-Sept 2024-Jun 2024-Mar
Promoter Holding 40.67% 40.64% 40.39% 40.22% 40.14% 40.03% 40.24% 41.40%
FII Holding 0.01% 0.00% 0.01% 0.00% 0.00% 0.00% 0.00% 0.00%
DII Holding 0.02% 0.02% 0.02% 0.04% 0.04% 0.03% 0.01% 0.00%
Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 38.12% 38.70% 39.03% 40.95% 41.73% 42.84% 43.82% 42.47%
Other Holding 21.18% 20.64% 20.55% 18.79% 18.09% 17.10% 15.93% 16.13%
Shareholder Count 10,240 10,777 11,121 11,508 11,734 12,514 11,759 12,502

Lotus Eye Hospital Share Dividend Screener - Share Yield Analysis

Check Lotus Eye Hospital dividend history with payout and yield data. View Lotus Eye Hospital dividend details including ex-dates and amounts for LOTUSEYE stock.
Period Dividend Per Share Dividend Yield
2026-March ₹0.00 0.00%
2025-March ₹0.00 0.00%
2024-March ₹0.00 0.00%
2023-March ₹0.00 0.00%
2022-March ₹0.50 0.87%
2021-March ₹0.50 0.94%
2020-March ₹0.00 0.00%
2019-March ₹0.00 0.00%
2018-March ₹0.50 2.27%
2017-March ₹0.50 1.81%

Lotus Eye Hospital Stock Index Membership

See which indices include Lotus Eye Hospital stock. Check LOTUSEYE index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Lotus Eye Hospital is not part of any tracked indices.
Only major market indices are tracked in our system.

Lotus Eye Hospital Market Events Screener - Corporate Actions

Get Lotus Eye Hospital corporate actions including splits, bonuses, and buybacks. Check Lotus Eye Hospital stock events that may affect LOTUSEYE share price.
Announcement Date Record Date Event Type Information Price Impact
Annual General Meeting NA 12.18%
Dividend ₹ 0.50 /share -10.42%
Dividend ₹ 0.50 /share 36.35%
Dividend ₹ 0.50 /share 11.71%
2026-02-11 2026-02-11 Quarterly Result Announcement NA -14.85%
2025-11-12 2025-11-12 Quarterly Result Announcement NA -2.78%
2025-08-12 2025-08-12 Quarterly Result Announcement NA 1.02%
2025-05-29 2025-05-29 Quarterly Result Announcement NA -1.24%
2025-02-12 2025-02-12 Quarterly Result Announcement NA 2.25%
2024-11-12 2024-11-12 Quarterly Result Announcement NA -7.91%
2024-08-13 2024-08-13 Annual General Meeting NA 5.50%
2017-06-06 2017-06-06 Change Of Name NA -

Lotus Eye Hospital Competitors Screener - Peer Comparison

Screen LOTUSEYE competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Apollo Hospitals 108,220 57.91 21,994 14.76% 1,505 52.72
Max Healthcare Institute 93,236 65.43 7,184 28.68% 1,076 39.91
Fortis Healthcare 64,621 65.24 7,850 13.25% 809 51.42
Narayana Hrudayalaya 36,274 46.01 5,575 12.29% 790 56.73
Aster DM Healthcare 34,916 98.30 4,287 15.12% 337 58.43
Global Health 28,574 55.71 3,771 12.59% 481 53.63
Krishna Institute of Medical Sciences 26,353 84.31 3,067 21.98% 415 53.23
Dr. Agarwal's Health Care 13,407 85.85 1,757 27.64% 110 52.86
Rainbow Childrens Medicare 13,051 48.85 1,567 17.46% 244 62.62
Kovai Medical Center Hospital 12,287 25.00 600 11.69% 58 56.99

Lotus Eye Hospital Company Announcements - News Screener

Screen LOTUSEYE latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
Date Update Actions
2026-04-09 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-03-26 Closure of Trading Window -
2026-03-17 Board Meeting Outcome for Outcome Of The Board Meeting -
2026-03-12 Board Meeting Intimation for To Consider The Proposal For Voluntary Delisting Of The Companys Equity Shares From NSE. -
2026-03-04 Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order -
2026-03-02 Disclosures under Reg. 10(6) of SEBI (SAST) Regulations 2011 -
2026-02-12 Board Comments On Imposition Of Fine Under Regulation 17(1A) Of SEBI (LODR) 2015 -
2026-02-12 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-02-12 Appointment of Company Secretary and Compliance Officer -
2026-02-11 Outcome Of The Board Meeting -
2026-02-11 Board Meeting Outcome for Outcome Of Board Meeting -
2026-02-09 Announcement under Regulation 30 (LODR)-Cessation -
2026-02-06 Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011 -
2026-01-30 Board Meeting Intimation for The Quarter Ended 31St December 2025 -
2026-01-27 Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations 2011 -
2026-01-19 Shareholder Meeting / Postal Ballot-Scrutinizer"s Report -
2026-01-05 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2025-12-26 Closure of Trading Window -
2025-12-24 Revision In Announcement Made On 18.12.2025 -
2025-12-19 Announcement under Regulation 30 (LODR)-Newspaper Publication -